Listed

Xtant Medical Holdings, Inc.: Form 10-K/A for the period ended Dec 31, 2017

Filed with the SEC on Apr 5, 2018 and accepted by EDGAR at Apr 5, 2018, 15:06 ET.

Share

Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2017-01-01 to 2017-12-31$32.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2017-01-01 to 2017-12-31$50.1mus-gaap:GrossProfit
Research and development12 months2017-01-01 to 2017-12-31$2.4mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2017-01-01 to 2017-12-31−$37.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$14.7mus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2017-01-01 to 2017-12-31−$52.4mus-gaap:NetIncomeLoss
Diluted EPS12 months2017-01-01 to 2017-12-31−$34.76us-gaap:EarningsPerShareDiluted
Basic EPS12 months2017-01-01 to 2017-12-31−$34.76us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2017-01-01 to 2017-12-311,507,769 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2017-01-01 to 2017-12-31−$543.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2017-01-01 to 2017-12-31$1.6mus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2017-12-31$2.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$39.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$105.7mus-gaap:Assets
Current liabilitiesAt period end2017-12-31$25.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$164.4mus-gaap:Liabilities
Shareholders' equityAt period end2017-12-31−$58.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-18-019363. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.